PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32375399-4	2020	SCH727965 (dinaciclib), a potent cyclin-dependent kinase (CDK) inhibitor, was shown to synergize with other drugs to get better efficacy.	dinaciclib	0-9	cyclin dependent kinase inhibitor 3	Homo sapiens	33-72	
32375399-4	2020	SCH727965 (dinaciclib), a potent cyclin-dependent kinase (CDK) inhibitor, was shown to synergize with other drugs to get better efficacy.	dinaciclib	11-21	cyclin dependent kinase inhibitor 3	Homo sapiens	33-72	
26585571-0	2016	Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines.	dinaciclib	0-10	cyclin dependent kinase inhibitor 3	Homo sapiens	14-47	
24393852-0	2014	Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer.	dinaciclib	67-77	cyclin dependent kinase inhibitor 3	Homo sapiens	33-66	
24393852-0	2014	Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer.	dinaciclib	79-86	cyclin dependent kinase inhibitor 3	Homo sapiens	33-66	
24393852-2	2014	Dinaciclib (MK-7965, formerly SCH727965), a small-molecule cyclin-dependent kinase inhibitor, has demonstrated antitumor activity in phase I studies with solid-tumor patients.	dinaciclib	0-10	cyclin dependent kinase inhibitor 3	Homo sapiens	59-92	
24393852-2	2014	Dinaciclib (MK-7965, formerly SCH727965), a small-molecule cyclin-dependent kinase inhibitor, has demonstrated antitumor activity in phase I studies with solid-tumor patients.	dinaciclib	12-19	cyclin dependent kinase inhibitor 3	Homo sapiens	59-92	
24393852-2	2014	Dinaciclib (MK-7965, formerly SCH727965), a small-molecule cyclin-dependent kinase inhibitor, has demonstrated antitumor activity in phase I studies with solid-tumor patients.	dinaciclib	30-39	cyclin dependent kinase inhibitor 3	Homo sapiens	59-92	
26300056-0	2015	Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.	dinaciclib	0-10	cyclin dependent kinase inhibitor 3	Homo sapiens	14-47	
26300056-1	2015	Dinaciclib is a novel cyclin-dependent kinase inhibitor (CDKI) with significant activity against various cancers in vitro and in vivo.	dinaciclib	0-10	cyclin dependent kinase inhibitor 3	Homo sapiens	22-55	
26300056-1	2015	Dinaciclib is a novel cyclin-dependent kinase inhibitor (CDKI) with significant activity against various cancers in vitro and in vivo.	dinaciclib	0-10	cyclin dependent kinase inhibitor 3	Homo sapiens	57-61